2-Aminooxazole → 5(S)-Oxazol-2-ylaminomethyl-3-(3-fluoro-4-(3,6-dihydro-(2H)-pyran-4-yl)phenyl)oxazolidin-2-one

To a stirred partial solution of 2-aminooxazole (169 mg, 2.0 mmol) in dry THF (10 ml), cooled to −78° C., under argon, was added slowly n-BuLi (1.33M, 1.5 ml, 2.0 mmol), followed after 1 h by 5(R)-methylsulfonyloxymethyl-3-(3-fluoro-4-(3,6-dihydro-(2H)-pyran-4-yl)phenyl)oxazolidin-2-one (see Example 41; 371 mg, 11.0 mol) suspended in dry THF (20 ml). The reaction was allowed to come to room temperature and then refluxed for 24 h. The reaction was quenched with ammonium chloride solution (10% w/v, 30 ml), extracting the mixture with chloroform (3×50 ml). The extracts were dried (magnesium sulfate), concentrated by rotary evaporation chromatographed by MPLC (Merck 9385 silica, 3–10% gradient methanol/dichloromethane eluent) and the pure fractions combined, concentrated and triturated with diethyl ether to give the title compound (25 mg, 4.6%).

1. customto come to room temperature
2. temperaturerefluxed for 24 h
3. customThe reaction was quenched with ammonium chloride solution (10% w/v, 30 ml)
4. extractionextracting the mixture with chloroform (3×50 ml)
5. dry with materialThe extracts were dried (magnesium sulfate)
6. concentrationconcentrated by rotary evaporation
7. customchromatographed by MPLC (Merck 9385 silica, 3–10% gradient methanol/dichloromethane eluent)
8. concentrationconcentrated
9. customtriturated with diethyl ether

ORD-Eintrag

ord-d36e2869281c45db888da5180557e81a

Quelldatensatz

uspto-grants-2006_08

DOI

10.6084/m9.figshare.5104873.v1

Patentnummer

US07087629B2